Long-Term Outcomes of Metabolic and Bariatric Surgery: Durability of Weight Loss, Metabolic Remission, and the Changing Treatment Landscape
Yoonhong Kim, Ki Hyun Kim, Seung Hun Lee, Yeajin Moon, Yeongdo Oh, Kyung Won Seo · 2026
Read Long-Term Outcomes of Metabolic and Bariatric Surgery: Durability of Weight Loss, Metabolic Remission, and the Changing Treatment Landscape by Yoonhong Kim, Ki Hyun Kim, Seung Hun Lee, Yeajin Moon, Yeongdo Oh, Kyung Won Seo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13158176.txt.
Description
Yoonhong Kim and five co-authors review the long-term results of metabolic and bariatric surgery for obesity. Obesity is a chronic disease that often returns and drives heart and metabolic harm. Surgery remains the most effective proven route to lasting weight loss, though new incretin-based drugs have changed the wider picture.
Long-term studies show surgery keeps weight down and holds type 2 diabetes, high blood pressure, and blood fat problems in lasting remission for many. Death rates and heart events run lower than with standard care. Results differ by operation. Gastric bypass tends to beat older restrictive procedures and, in some cases, sleeve gastrectomy, which raises concern about reflux over time. The strongest operations bring heavier nutritional burdens. The authors argue surgery should be judged as a disease-modifying treatment, and drugs can serve as an add-on or as a step in sequence.
Catalog record
| CREATOR | Yoonhong Kim, Ki Hyun Kim, Seung Hun Lee, Yeajin Moon, Yeongdo Oh, Kyung Won Seo |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |